Depending on which corporation is referenced by the ticker symbol OGN, the financial debt profile varies entirely. If referring to Orogen Royalties Inc. (traded on the TSX Venture Exchange as OGN), the company operates with a pristine balance sheet carrying zero long-term debt and maintains a strong net cash and working capital position. Conversely, if referring to the global healthcare company Organon & Co. (traded on the NYSE as OGN), the enterprise carries a substantial long-term debt load totaling approximately $8.55 billion to $8.57 billion, balanced against significant global pharmaceutical revenues, established brand portfolios, and multi-billion-dollar annual cash flows.